Study on prevalence of hepatitis B in pregnant women and its effect on maternal and fetal outcome at tertiary care centre

Sunita Mishra; Priyali Purandre; Ratna Thakur; Shweta Agrawal; Madhuri Alwani

doi:10.18203/2320-1770.ijrcog20172069

Authors

Sunita Mishra Department of Obstetrics and Gynecology, Sri Aurobindo Medical College and Postgraduate Institute, Near Mr-10 Crossing, Sanwer Road, Indore, Madhya Pradesh, India
Priyali Purandre Department of Obstetrics and Gynecology, Sri Aurobindo Medical College and Postgraduate Institute, Near Mr-10 Crossing, Sanwer Road, Indore, Madhya Pradesh, India
Ratna Thakur Department of Obstetrics and Gynecology, Sri Aurobindo Medical College and Postgraduate Institute, Near Mr-10 Crossing, Sanwer Road, Indore, Madhya Pradesh, India
Shweta Agrawal Department of Obstetrics and Gynecology, Sri Aurobindo Medical College and Postgraduate Institute, Near Mr-10 Crossing, Sanwer Road, Indore, Madhya Pradesh, India
Madhuri Alwani Department of Obstetrics and Gynecology, Sri Aurobindo Medical College and Postgraduate Institute, Near Mr-10 Crossing, Sanwer Road, Indore, Madhya Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20172069

Keywords:

Hepatitis B surface antigen, Pregnant woman, Prevalence

Abstract

Background: Hepatitis-B is caused by double stranded DNA virus. Prevalence of hepatitis B in pregnant woman worldwide is 2.5 to 1.5% whereas in India it is 2 to 7.7%.

Methods: This is a retrospective study conducted at SAMC and PGI, Indore between January 2016 to December 2016. Hepatitis- B prevalence and outcome was assessed by doing routine screening of hepatitis B antigen in our indoor patients and finding out their maternal and fetal outcome.

Results: Total 3567 deliveries were conducted during study period, out of them 39 were diagnosed as HbsAg positive pregnant patient; so, prevalence was found to be 1.09%. out of these, 84.6% were booked cases, mode of delivery was vaginal in 66.67% cases, preterm Delivery was in 10.26% of cases, meconium stained liquor was found in 5.13% cases, maternal mortality was nil, perinatal mortality was found in 2.56% cases and 5.13% cases were admitted in NICU.

Conclusions: Screening of all pregnant women for HbsAg irrespective of risk factors will definitely help to know the correct prevalence and reduce the transmission of hepatitis B infection. Hepatitis B is a major public health problem in India and will continue to be until appropriate nationwide vaccination programs and other control measures are established.

Metrics

Metrics Loading ...

References

Gukk HH, Majumdar PD, dhurinjiboy KR, Desai HG, prevalence of Hepatitis B, antigen in pregnant women and patients with liver disease. J Assoc. Physicians of India. 1995;43:247-48.

Kolawole OM, Wahab AA, Adekanle DA, Sibanda T, Okoh AI. Seroprevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria. Virol J. 2012;9:317.

Jonas MM, Reddy RK, Demedina M, Sehiff ER. Hepatitis B infection in large municipal obstetric population: characterization and preventon of perinatal transmission Am J Gastroenterol. 1990;85:277.

Yang HI, Lu SN, Liaw YF, You SL, Sun CA, wang LY et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med. 2002;347:168-174.

American college of Obstetricians and Gynecologists ACOG Practice Bulletin No.86: Viral hepatitis in pregnancy. Obstet Gynecol. 110:941-956.

Sheila S. Hepatitis B. in; Diseases of the liver and biliary system 10th Ed. Blackwell. 2001;272-6.

Chatterjee S, Ravishankar K, Chatterjee R, Narang A, Kinikar A. Hepatitis B Prevalence during pregnancy. Indian Pediatrics. 2009;46(11):1005-8.

André FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol. 1994;44:144-51.

Lobste S, Faber R, Tillmann HL. Prevalence of hepatitis B among pregnant women and its impact on pregnancy and newborn complications at a tertiary hospital in the eastern part of Germany. Digestion. 2011;83:76-82.

Zali R, Mohammad K, Farhadi A, Masjedi MR, Zargar A and Nowroozi A. Epidemiology of hepatitis B in the IR of Iran. EMHJ. 1996;2(2):290-8.

Katke RD. The impact of maternal HbsAg carrier status on pregnancy outcomes: an institutional experience; Katke, Gynecol Obstet. (sunnyvale). 2015;5:5.

Afzali H, Heravi M, Moravveji SA, Poorrahnama M. Prevalence of Hepatitis B Surface Antigen in Pregnant Women in Beheshti Hospital of Kashan, Isfahan; Iranian Red crescent medical journal’ Rec. 2014;24.

Tse KY, Ho LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. J Hepatol. 2005;43:771-5.

Wong S, chan LY, Yu V, Ho L. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol. 2015;16:485-8.

Merat S, Malekzadeh R. Hepatitis B in Iran. Arc Irn Med J. 2003;4:192-201.